These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22674100)

  • 1. Preventing overcorrection of hyponatraemia with desmopressin.
    Tomlin SC; Williams R; Riley S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
    Ochiai H; Uenishi E
    Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing hyponatraemia secondary to primary polydipsia: beware too rapid correction of hyponatraemia.
    Boehm E; Kumar S; Nankervis A; Colman P
    Intern Med J; 2017 Aug; 47(8):956-959. PubMed ID: 28782208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP to prevent rapid correction in hyponatremia.
    Goldszmidt MA; Iliescu EA
    Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
    MacMillan TE; Tang T; Cavalcanti RB
    Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
    Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
    Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
    Velez JC; Dopson SJ; Sanders DS; Delay TA; Arthur JM
    Nephrol Dial Transplant; 2010 May; 25(5):1524-31. PubMed ID: 20064953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
    Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
    Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
    ten Doesschate T; Reichert LJ; Claassen JA
    Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic demyelination syndrome following slow correction of hyponatraemia.
    Saunders I; Williams DM; Ruslan AM; Min T
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34373247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
    Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
    Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
    Rajendran R; Grossman AB; Kar P
    Endocr J; 2012; 59(10):903-9. PubMed ID: 22785335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
    Spatenkova V; Bradac O; Skrabalek P
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
    Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
    Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
    Watterworth BS; Noorani RJ
    A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.